Ledger.Open graph →
SEC Form D · filed March 2, 2021

Tulavi Therapeutics, Inc

Offering
$10.0M
Sold
$7.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MOUNTAIN VIEW, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Henry Chen · Mountain View, CADirectorSteve Willamson · Mountain View, CADirectorCorinne Bright · Mountain View, CAExec · DirectorTara Butler · Mountain View, CADirectorFarhad Khosravi · Mountain View, CADirectorAmar Sawhney · Mountain View, CADirectorDavid Pearah · Lenexa, KSExec · DirectorWon Yang · Galveston, TXDirectorEric Goettelmann · Saint Louis, MODirectorWilliam Conroy · Lenexa, KSDirectorLon Chow · Lenexa, KSDirectorJ.T. Norville · Saint Louis, MODirectorJoseph Corcoran · New York, NYDirectorSamuel Riter · New York, NYExec · DirectorJ.S. White Oak Specialized ABL Partners, LLC · San Francisco, CADirectorKevin Sun · Carbondale, ILDirectorNoah Fulk · Carbondale, ILDirectorChristian A. Diez · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗